SEC Tracker
Get the app

Bambusa Therapeutics BBTX

Bambusa Therapeutics reports ownership

Salvia Investment GmbH, new insider at Bambusa Therapeutics, Inc.

Form
3
Filed
Importance
Routine
  1. Salvia Investment GmbH owns 4,119,600 common shares
  2. Salvia Investment GmbH holds 3,135,066 shares from Series Seed Preferred Stock
  3. Salvia Investment GmbH holds 1,473,775 shares from Series A-1 Preferred Stock
  4. Salvia Investment GmbH holds 160,860 shares from Series A-2 Preferred Stock

Written from the Form 3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Bambusa Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX